Global Hematology Diagnostics Report Thumbnail

Global Hematology Diagnostics Market by Type (Hematology Instruments, Hematology Consumables), By Application (Diagnostic Laboratories, Hospitals & Clinics, Academic Institutes, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

  • Report ID: MDC-370
  • Author: Up Market Research
  • Rating: 4.6
  • Total Reviews: 97
  • No. Of Pages: 246
  • Format:
  • Pub. Date: 2021-03-01
  • Share:

The Global Hematology Diagnostics Market size is expected to grow from USD 2.61 billion in 2021, to reach USD 3.89 billion by 2028, with a CAGR of 6.1% for the period of 2021-2028. The North American region dominated the global hematology diagnostics market and accounted for over 48% share of all revenue generated in 2017 due to the increased prevalence of diseases such as leukemia, lymphoma, Hodgkin's disease, and myeloma among adults aged 45 years or above in this region. In addition, countries like China are witnessing an increase in cancer cases which has led to a growing demand for diagnostic equipment used during the diagnosis process for cancer patients throughout Asia Pacific Market.


Hematology Diagnostics can be defined as the process of assessing blood cells and their functions to diagnose, monitor, and manage diseases. It is a branch of clinical pathology that deals with disorders related to red blood cells (erythrocytes), white blood cells (leukocytes), and platelets in the blood. Hematology Diagnostics can be used for diagnosing several types of medical conditions from anemia to leukemia as well as monitoring people who have received chemotherapy treatment or had certain procedures such as x-rays.


On the basis of Type, the market is segmented into Hematology Instruments and Hematology Consumables.


Hematology Instruments:

Hematology instruments are designed to perform hematological tests which analyze the quality of blood cells. They typically come in three types: counting, measuring, and analyzing. Counting devices measure a cell’s size and shape while an analysis device will observe changes caused by parasites or malignant growths. One type of instrument is labeled as measurement-analyzing because it does both jobs with different modes for each process.


Hematology Consumables:

Hematology consumables consist of a variety of processed materials, including reagents and chemicals, media for culturing bacteria and fungi, buffers, stains, and fixatives. They are used in hematological diagnostic procedures to analyze blood cells or bone marrow samples. Hematology Consumables can be defined as a broad category of items that are used to support the diagnosis and treatment of diseases. These products include blood collection tubes, fluid processing devices, containers for transport media as well as therapeutic agents such as heparin.


On the basis of Application, the market is segmented into Diagnostic Laboratories, Hospitals and Clinics, Academic Institutes, and Others. The diagnostic laboratories segment is expected to dominate the global hematology diagnostics market during the forecast period due to increased demand for more effective methods of blood cell analysis.

The hospitals and clinics segment includes diagnostic laboratories, as well as hospital pharmacies that provide patient care services including hematology diagnostics in addition to other medical specialties such as oncology or cardiology. Other segments include military markets globally who might use this technology during active conflict zones due to its efficiency in detecting hematological disorders.


On the basis of Region, the market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The European market accounts for the largest share of the global hematology diagnostics market. The Asia Pacific region is expected to witness significant growth in this sector from 2021-2028, owing to the rapid adoption of technology and cost competitiveness.

The Americas hematology diagnostics market is expected to grow at the highest CAGR during the forecast period due to the increased adoption of new diagnostic techniques such as molecular methods for detection in this region. The U.S accounts for the largest share of North America’s hematology diagnostic market due to its favorable reimbursement policies and advanced healthcare infrastructure coupled with increasing prevalence rates of certain diseases that require monitoring like leukemia, myeloma, lymphoma, etc. The growth within this region can also be attributed to continuous advancements being made by pharmaceutical companies pertaining mainly to new drug launches which result in increased sales across all segments under investigation.


Growth Factors For The Global Hematology Diagnostics Market:

The global hematology diagnostics market is projected to grow at a higher pace during the forecast period, primarily driven by factors such as increasing healthcare expenditure and aging population, which has led to an increase in the prevalence of chronic diseases like anemia and leukemia that need regular monitoring with laboratory tests. However, high costs associated with the diagnosis process may pose a challenge for growth in this market. Furthermore, a lack of awareness on erythrocyte sedimentation rate (ESR) testing among physicians can also hinder the growth potential for these products over the assessment period from 2021-2028.

As the global hematology market continues to grow, its segmentation is also undergoing changes. New players are now entering this field with improved technologies and novel testing tools that have been developed in response to changing disease patterns and treatment needs of multidrug-resistant bacteria. As a result, there has been an increase in demand for point-of-care kits (POCT) which can help achieve cost efficiencies through minimally invasive diagnostics. The future of the hematology industry looks promising as it will continue to innovate diagnostic techniques such as advanced molecular assays and automation coupled with higher adoption rates among healthcare facilities across various geographies.

Up Market Research published a new report titled “Hematology Diagnostics Market research report which is segmented by Types (Hematology Instruments, Hematology Consumables), By Applications (Diagnostic Laboratories, Hospitals & Clinics, Academic Institutes, Others), By Players/Companies Abbott Laboratories, Sysmex Corporation, F. Hoffmann-La Roche, Beckman Coulter”. 


Report Scope

Report Attributes Report Details
Report Title Hematology Diagnostics Market Research Report
By Type Hematology Instruments, Hematology Consumables
By Application Diagnostic Laboratories, Hospitals & Clinics, Academic Institutes, Others
By Companies Abbott Laboratories, Sysmex Corporation, F. Hoffmann-La Roche, Beckman Coulter
Regions Covered North America, Europe, APAC, Latin America, MEA
Base Year 2020
Historical Year 2018 to 2019 (Data from 2010 can be provided as per availability)
Forecast Year 2028
Number of Pages 246
Number of Tables & Figures 173
Customization Available Yes, the report can be customized as per your need.

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Hematology Diagnostics Industry Outlook

Global Hematology Diagnostics Market Report Segments:

The market is segmented by Type Hematology Instruments, Hematology Consumables and By Application Diagnostic Laboratories, Hospitals & Clinics, Academic Institutes, Others.


Some of the companies that are profiled in this report are:

  1. Abbott Laboratories
  2. Sysmex Corporation
  3. F. Hoffmann-La Roche
  4. Beckman Coulter

Hematology Diagnostics Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.


Key Benefits for Industry Participants & Stakeholders:

  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Hematology Diagnostics Market

Overview of the regional outlook of the Hematology Diagnostics Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Hematology Diagnostics Market Overview

Highlights of The Hematology Diagnostics Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of Hematology Diagnostics Market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2028.
  5. Developments and trends in the market.
  6. By Type:

                1. Hematology Instruments

                2. Hematology Consumables

       7. By Application:

                1. Diagnostic Laboratories

                2. Hospitals & Clinics

                3. Academic Institutes

                4. Others

  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Hematology Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.


How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Hematology Diagnostics Market Statistics

Reasons to Purchase the Hematology Diagnostics Market Report:

  • The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
  • Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
  • Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
  • The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
  • Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hematology Diagnostics Market Overview
   4.1 Introduction 
      4.1.1 Market Taxonomy 
      4.1.2 Market Definition 
      4.1.3 Macro-Economic Factors Impacting the Market Growth 
   4.2 Hematology Diagnostics Market Dynamics 
      4.2.1 Market Drivers 
      4.2.2 Market Restraints 
      4.2.3 Market Opportunity 
   4.3 Hematology Diagnostics Market - Supply Chain Analysis 
      4.3.1 List of Key Suppliers 
      4.3.2 List of Key Distributors 
      4.3.3 List of Key Consumers 
   4.4 Key Forces Shaping the Hematology Diagnostics Market 
      4.4.1 Bargaining Power of Suppliers 
      4.4.2 Bargaining Power of Buyers 
      4.4.3 Threat of Substitution 
      4.4.4 Threat of New Entrants 
      4.4.5 Competitive Rivalry 
   4.5 Global Hematology Diagnostics Market Size & Forecast, 2018-2028 
      4.5.1 Hematology Diagnostics Market Size and Y-o-Y Growth 
      4.5.2 Hematology Diagnostics Market Absolute $ Opportunity 

Chapter 5 Global Hematology Diagnostics Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Hematology Diagnostics Market Size Forecast by Type
      5.2.1 Hematology Instruments
      5.2.2 Hematology Consumables
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Hematology Diagnostics Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Hematology Diagnostics Market Size Forecast by Applications
      6.2.1 Diagnostic Laboratories
      6.2.2 Hospitals & Clinics
      6.2.3 Academic Institutes
      6.2.4 Others
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Hematology Diagnostics Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Hematology Diagnostics Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Hematology Diagnostics Analysis and Forecast
   9.1 Introduction
   9.2 North America Hematology Diagnostics Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Hematology Diagnostics Market Size Forecast by Type
      9.6.1 Hematology Instruments
      9.6.2 Hematology Consumables
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Hematology Diagnostics Market Size Forecast by Applications
      9.10.1 Diagnostic Laboratories
      9.10.2 Hospitals & Clinics
      9.10.3 Academic Institutes
      9.10.4 Others
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Hematology Diagnostics Analysis and Forecast
   10.1 Introduction
   10.2 Europe Hematology Diagnostics Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Hematology Diagnostics Market Size Forecast by Type
      10.6.1 Hematology Instruments
      10.6.2 Hematology Consumables
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Hematology Diagnostics Market Size Forecast by Applications
      10.10.1 Diagnostic Laboratories
      10.10.2 Hospitals & Clinics
      10.10.3 Academic Institutes
      10.10.4 Others
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Hematology Diagnostics Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Hematology Diagnostics Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Hematology Diagnostics Market Size Forecast by Type
      11.6.1 Hematology Instruments
      11.6.2 Hematology Consumables
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Hematology Diagnostics Market Size Forecast by Applications
      11.10.1 Diagnostic Laboratories
      11.10.2 Hospitals & Clinics
      11.10.3 Academic Institutes
      11.10.4 Others
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Hematology Diagnostics Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Hematology Diagnostics Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Hematology Diagnostics Market Size Forecast by Type
      12.6.1 Hematology Instruments
      12.6.2 Hematology Consumables
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Hematology Diagnostics Market Size Forecast by Applications
      12.10.1 Diagnostic Laboratories
      12.10.2 Hospitals & Clinics
      12.10.3 Academic Institutes
      12.10.4 Others
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Hematology Diagnostics Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Hematology Diagnostics Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Hematology Diagnostics Market Size Forecast by Type
      13.6.1 Hematology Instruments
      13.6.2 Hematology Consumables
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Hematology Diagnostics Market Size Forecast by Applications
      13.10.1 Diagnostic Laboratories
      13.10.2 Hospitals & Clinics
      13.10.3 Academic Institutes
      13.10.4 Others
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Hematology Diagnostics Market: Competitive Dashboard
   14.2 Global Hematology Diagnostics Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Abbott Laboratories
      14.3.2 Sysmex Corporation
      14.3.3 F. Hoffmann-La Roche
      14.3.4 Beckman Coulter
Segments Covered in the Report
The global Hematology Diagnostics market has been segmented based on

By Types
  • Hematology Instruments
  • Hematology Consumables
By Applications
  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Academic Institutes
  • Others
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • Abbott Laboratories
  • Sysmex Corporation
  • F. Hoffmann-La Roche
  • Beckman Coulter

Buy Report